Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:31:06 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



News for U:BIOL from 2023-05-18 to 2024-05-17 - 32 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-13 16:07U:BIOLNews ReleaseBiolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability
2024-05-06 06:31U:BIOLNews ReleaseBIOLASE to Report First Quarter 2024 Results on May 13, 2024
2024-03-21 16:08U:BIOLNews ReleaseBiolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
2024-03-14 06:31U:BIOLNews ReleaseBIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024
2024-02-22 06:42U:BIOLNews ReleaseBiolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
2024-02-20 06:32U:BIOLNews ReleaseBiolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
2024-02-15 14:46U:BIOLNews ReleaseBIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
2024-02-14 06:31U:BIOLNews ReleaseBIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
2024-02-13 09:17U:BIOLNews ReleaseBIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
2024-01-29 06:30U:BIOLNews ReleaseBIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024
2024-01-08 16:05U:BIOLNews ReleaseBIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023
2024-01-03 16:05U:BIOLNews ReleaseBIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
2023-12-14 16:05U:BIOLNews ReleaseBIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
2023-12-12 16:05U:BIOLNews ReleaseBIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial
2023-12-06 13:46U:BIOLNews ReleaseBIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2023-11-09 16:05U:BIOLNews ReleaseBIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES
2023-11-08 06:30U:BIOLNews ReleaseLandmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR ‚ ® Perio Protocol
2023-11-07 16:05U:BIOLNews ReleaseBIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023
2023-10-18 08:00U:BIOLNews ReleaseSWK Holdings Highlights Recent Achievements and Provides Portfolio Update
2023-09-18 16:30U:BIOLNews ReleaseBIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
2023-09-13 23:16U:BIOLNews ReleaseBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
2023-08-10 16:05U:BIOLNews ReleaseBIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
2023-08-02 16:05U:BIOLNews ReleaseBIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10, 2023
2023-07-26 16:30U:BIOLNews ReleaseBIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT
2023-07-17 06:30U:BIOLNews ReleaseBIOLASE EPIC HYGIENE DENTAL LASER RECEIVES PRESTIGIOUS CELLERANT BEST OF CLASS HYGIENE AWARD
2023-06-15 06:30U:BIOLNews ReleaseBIOLASE Announces Grand Opening of Training Facility to Reach Wider Universe of Dental Practitioners; First-Hand Experience Using Leading Dental Laser Technology Expected to Generate Increased Revenue Opportunities
2023-06-14 16:05U:BIOLNews ReleaseBIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2023 VIRTUAL HEALTHCARE CONFERENCE HOSTED BY M-VEST ON JUNE 20TH - 22ND
2023-06-14 06:30U:BIOLNews ReleaseBIOLASE INTEGRATES DIODE LASER TECHNOLOGY WITH PET DENTAL SERVICES
2023-06-05 17:30U:BIOLNews ReleaseBIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK
2023-06-05 07:14U:BIOLNews ReleaseBIOLASE Takes Steps to Improve Operating Efficiency as the Company Pursues Sales and Profitability Goals
2023-05-26 11:25U:BIOLNews ReleaseBIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
2023-05-24 09:14U:BIOLNews ReleaseBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants